What Is Quality by Design in Pharmaceutical Development?UntitledA Science-Led Route to Built-In Quality
Quality by Design (QbD) training gives pharmaceutical and biopharmaceutical teams in Italy a systematic, science-based way to build quality into a product from the design stage rather than testing it in at the end. Grounded in the ICH Q8(R2) Pharmaceutical Development guideline and the wider ICH Q9, Q10 and Q11 framework, the programme shows how quality becomes an outcome of understanding, not inspection. Over one focused day, you learn to define the Quality Target Product Profile, identify Critical Quality Attributes, link them to material attributes and process parameters through risk assessment, explore the design space with Design of Experiments, and lock it into a Control Strategy. These are the tools the EMA and FDA now expect to see in CTD submissions. The course suits formulation scientists, process and analytical specialists, QA professionals and CMC regulatory teams working across Italy's pharmaceutical clusters in Lombardy, Lazio and Emilia-Romagna. You leave able to apply QbD on live development projects straight away, with a course completion record from Invensis Learning.










